Mohleen Kang MD
@KangMohleen
Followers
420
Following
538
Media
58
Statuses
255
Pulmonary and Critical care @EmoryPCCM @atlantaVAMC, patient centered outcomes research and MCID in ILD, #femaledoc, views are my own
Atlanta, GA
Joined October 2018
My first podcast for @ATSBlueEditor #OutofBlue podcast. Looking forward to more!
Don't miss the latest episode of #OutoftheBlue! This week's episode: External Control Arms in Idiopathic Pulmonary Fibrosis Using Clinical Trial and Real-World Data Sources and The Added Power of Synthetic Control Groups... Listen Here 🔈
1
1
5
This was an absolute pleasure to record. Didn’t realize how much we talked. Thanks
NEW!!!! 🎙️#419 Rapid Response Series: Sepsis with Dr. Mohleen Kang A shock to the system @KangMohleen @EmoryUniversity 🦠Join us for an infectious conversation about sepsis as we learn about the recognition + initial management of sepsis on the wards @monsta23 @MeredithTrubitt
0
1
4
Perfect end to a busy week in the ICU:)
0
1
7
Hats off to @ATLairport! The fastest @TSA precheck lines ever during this Thanksgiving holiday rush. Thank you for all that you do!
0
0
0
0
0
0
And it’s ON! #chestchallenge2021 with @OSUPCCM_Fellows gets to pick the first question! And SUNY Buffalo gets the first score on the board!
1
0
1
It was definitely one of the highlights of the fellowship. Thanks @davidschulman and @EmoryPCCM for giving me the opportunity to be on the team:) can’t wait for #chestchallenge2021 #CHEST2021
What's one of the best experiences of your fellowship? For Mohleen Kang, MD, it was winning #CHESTChallenge2018 for Emory. Watch this Tuesday for the 20th anniversary year competition. #CHESTChallenge2021 @KangMohleen #CHEST2021
0
0
4
Sometimes you just need to unplug from daily life:) luckily lots of hiking 1-2 hours away from Atlanta. #perfectfallweather @EmoryPulmonary @EmoryPCCM @Amicalola_Falls
1
0
15
My MSCR thesis project is finally published! Thanks to mentors @gsmartinmd, JordanKempker & Srihari Veeraraghavan. An updated approach to determine minimal clinically important differences in idiopathic pulmonary fibrosis. @ERSpublications
1
2
7
So thankful to my co-authors and mentors: Srihari Veeraraghavan, Lucian Marts, Jordan Kempker and @gsmartinmd. Twitter thread on MCID coming soon! Stay tuned.
0
0
1
Review Article: Minimal clinically important difference (MCID) values for common physiological and patient-reported outcome measures have been estimated in IPF, but have limitations. MCID research can help advance patient-oriented management of IPF.
1
5
26
After 4 years of we are all done with training! While sadly that means time for goodbyes, our future is as bright as the sunshine in GA:) #Finallydone #bestcofellows @EmoryPCCM @EmoryPulmonary @EmmGeezee @rramonell @aianwong
3
2
22
Check out @KangMohleen sharing her recent experience as a #mentee in the @ATSCPAssembly Mentorship Program. TODAY is the LAST DAY to sign up for this year's Mentorship Program as a #mentor or #mentee! https://t.co/2ZKtq4MPuO
1
5
11
Was so happy that I matched with Sonye! Dear mentors, this program would not be possible without your participation. #ATS2021
"I'd encourage each of you to participate in the Mentorship Program either as a #mentor or a #mentee" - Sonye Danoff, MD, @HopkinsPCCM and chair of the ATS Clinical Problems Assembly. DEADLINE to sign up is TODAY: https://t.co/mhjCCVLMHB
#ATS2021 @atscommunity @atsearlycareer
0
0
0
Enjoyed the Van Gogh Immersive Experience with @EmmGeezee! Thank you science for COVID vaccine! Weekend date with co fellow (now co-attending) after so long! @EmoryPCCM @EmoryPulmonary
3
1
15
Are you an early career professional looking to get more involved in ATS? @atscommunity @atsearlycareer Sign up for the @ATSCPAssembly mentoring program! Listen to @AKochMD share her experiences as a #mentee and register by Monday May 24th: https://t.co/2ZKtq4MPuO
#ATS2021
0
6
12
I have always enjoyed these sessions and this year at #ATS2021 was no different (other than the virtual part but there is next year)! The presenters took the debate part seriously, often taking subtle shots at their opponents. It was done with much love and respect though:)
Good Afternoon! We will be live tweeting #ATS2021 session "D011 Conundrums and Controversies In Diagnosis and Management of ILD: PRO/CON Debates (3:30-5:00 EDT)" moderated by @GaneshRaghuMD1 and @BridgetFCollins. @KangMohleen will be your twitter guide. Bring your own popcorn!
0
0
2